Profiling of 1,250 Neuroendocrine Tumors Identifies Multiple Potential Drug Targets

Authors:

Igor A. Astsaturov, Steven J. Cohen, Paul F. Engstrom, Zoran Gatalica, Ryan P. Bender, Gargi Dan Basu, Sherri Z. Millis

Abstract

Identification of new drug targets may extend treatment options for neuroendocrine tumors (NET), regardless of histologic classification or primary organ site.

Download Publication